F-15 Pilot with F-15 Pilot with ACOUSTIC NEUROMA ACOUSTIC NEUROMA
Capt. Nazim ATACapt. Nazim ATA
Aerospace Medicine Specialist Aerospace Medicine Specialist Turkish Air ForceTurkish Air Force
AAMIMO 2013AAMIMO 2013
Disclosure InformationDisclosure Information8484thth Annual AsMA Scientific Meeting Annual AsMA Scientific Meeting
Nazim ATANazim ATA
• I have no financial relationships to disclose.I have no financial relationships to disclose.
• I will not discuss off-label use and/or I will not discuss off-label use and/or investigational use in my presentation investigational use in my presentation
33
Clinical PresentationClinical Presentation• Pilot profilePilot profile• Present illnessPresent illness• HistoryHistory• TreatmentTreatment• Follow-upFollow-up
Acoustic Neuroma OverviewAcoustic Neuroma Overview
Aeromedical Concerns Aeromedical Concerns
Aeromedical Disposition and WaiverAeromedical Disposition and Waiver
ACS EvaluationACS Evaluation
Scope of PresentationScope of Presentation
44
Clinical PresentationClinical Presentation
Pilot Profile:Pilot Profile:
• Sex: FemaleSex: Female
• Age: 29 years oldAge: 29 years old
• Rank: Captain Rank: Captain
• Aircraft: F-15Aircraft: F-15
• Flying Hours: 1750 Flying Hours: 1750
55
• PPast few years - Preferred to hear conversations ast few years - Preferred to hear conversations
in her left earin her left ear
• Dec 2011 - Hearing loss was discovered on Dec 2011 - Hearing loss was discovered on
routine routine periodic health assessmentperiodic health assessment
Clinical PresentationClinical Presentation
66
• Fall 2010 - Difficulty with ocular trackingFall 2010 - Difficulty with ocular tracking• Had to stop to read food labels Had to stop to read food labels • Unable to read them while walking Unable to read them while walking
• No other ocular difficulties while flying No other ocular difficulties while flying
• Noticed difficulties Noticed difficulties • After missions when she was fatiguedAfter missions when she was fatigued• Following other heavy physical exertion Following other heavy physical exertion
Clinical PresentationClinical Presentation
77
• Headaches on awakeningHeadaches on awakening
• Resolved several hours after awakening Resolved several hours after awakening
• Not accompanied by nausea or vomitingNot accompanied by nausea or vomiting
• About 2/10 in intensityAbout 2/10 in intensity
• Dull in characterDull in character
• Diffuse in locationDiffuse in location
Clinical PresentationClinical Presentation
88
• Around this time, noticed some new clumsiness Around this time, noticed some new clumsiness
when working outwhen working out
• When the hearing loss was noted on periodic When the hearing loss was noted on periodic
health assessment, initially felt to be otitis media and health assessment, initially felt to be otitis media and
was briefly placed on antibiotics. was briefly placed on antibiotics.
• However, the history prompted a more detailed However, the history prompted a more detailed
exam exam
Clinical PresentationClinical Presentation
99
• Dec 2011- MRI study: Dec 2011- MRI study:
• Right cerebello-pontine angle massRight cerebello-pontine angle mass
• Pressure on the brainstemPressure on the brainstem
• Obstructive hydrocephalus. Obstructive hydrocephalus.
Clinical PresentationClinical Presentation
1010
• Past medical history: Past medical history: Not significantNot significant
• Social history:Social history:Tobacco: NeverTobacco: NeverAlcohol: 2 glasses of wine/week Alcohol: 2 glasses of wine/week
• Family History:Family History:Not significantNot significant
Clinical PresentationClinical Presentation
• Dec 2011 - Trans-labrynthine decompressive Dec 2011 - Trans-labrynthine decompressive
surgery with sacrifice of the right acoustic nerve surgery with sacrifice of the right acoustic nerve
and vestibular apparatusand vestibular apparatus
• Pathologic Diagnosis: SchwannomaPathologic Diagnosis: Schwannoma
• Genetic testing for Neurofibromatosis-2 was Genetic testing for Neurofibromatosis-2 was
negativenegative
1111
TreatmentTreatment
• Postoperatively Postoperatively
• Right facial weaknessRight facial weakness
• Vertigo Vertigo
1212
TreatmentTreatment
10 days post-op cerebrospinal fluid (CSF) 10 days post-op cerebrospinal fluid (CSF)
rhinorrhearhinorrhea
• Initial unsuccessful lumbar drainage Initial unsuccessful lumbar drainage
surgery surgery
• Jan 2012 - Surgery eliminated Jan 2012 - Surgery eliminated CSF CSF
leakageleakage
1313
TreatmentTreatment
1414
• Ocular tracking symptoms and facial weakness Ocular tracking symptoms and facial weakness
gradually resolvedgradually resolved
• Still noted very mild facial asymmetryStill noted very mild facial asymmetry
• Dryness of the right eye that required treatment Dryness of the right eye that required treatment
with artificial tears for a few monthswith artificial tears for a few months
Follow-up After SurgeryFollow-up After Surgery
1515
• Residual unsteadiness treated with vestibular Residual unsteadiness treated with vestibular
rehabilitationrehabilitation
• Symptoms resolved about four months Symptoms resolved about four months
postoperativelypostoperatively
Follow-up After SurgeryFollow-up After Surgery
1616
• Mar 2012 - Brain MRI: Mar 2012 - Brain MRI:
• Postoperative changes Postoperative changes
• Resolution of hydrocephalus Resolution of hydrocephalus
• Minimal residual mass effectMinimal residual mass effect
• Mar 2012 - Full Spine MRI:Mar 2012 - Full Spine MRI:
• No evidence of tumorsNo evidence of tumors
Follow-up MRIFollow-up MRI
1717
• Residual deafness Residual deafness
• Very minimal right facial asymmetry Very minimal right facial asymmetry
• Rare right eye dryness Rare right eye dryness
• Artificial tearsArtificial tears
• Minimal unsteadinessMinimal unsteadiness
• No other neurologic symptomsNo other neurologic symptoms
Follow-upFollow-up
1818
Acoustic Neuroma OverviewAcoustic Neuroma Overview
• Acoustic NeuromaAcoustic Neuroma
• Benign Schwann cell derived tumorsBenign Schwann cell derived tumors
• Arising from the inferior vestibular branch of the Arising from the inferior vestibular branch of the
CN-VIIICN-VIII
1919
Acoustic Neuroma OverviewAcoustic Neuroma Overview
• The overall incidenceThe overall incidence
• 1:100,0001:100,000
• Appears to be increasingAppears to be increasing
• IncidenceIncidence
• Peaks in the fifth and sixth decadesPeaks in the fifth and sixth decades
• Both sexes are affected equallyBoth sexes are affected equally
2020
Acoustic Neuroma OverviewAcoustic Neuroma Overview
• Generally slow growing tumorsGenerally slow growing tumors
• Symptoms Symptoms
• Hearing lossHearing loss
• TinnitusTinnitus
• Dizziness/balance issuesDizziness/balance issues
• Facial nerve paralysisFacial nerve paralysis
• Trigeminal nerve disordersTrigeminal nerve disorders
21
Acoustic Neuroma OverviewAcoustic Neuroma Overview
• Its treatments (surgery and radio-surgery) can Its treatments (surgery and radio-surgery) can
provoke complicationsprovoke complications
• CSF leakCSF leak
• Facial palsyFacial palsy
• Hearing lossHearing loss
2222
Acoustic Neuroma OverviewAcoustic Neuroma Overview
• Tumors are classified based on size:
Grade 1: small tumors measuring 1-10 mm
Grade 2: medium tumors measuring 11-20 mm
Grade 3: moderately-large tumors measuring 21-30 mm
Grade 4: large tumors measuring 31-40 mm
Grade 5: giant tumors those measuring more than 40 mm
2323
• Primary aeromedical concerns relate to the
neurologic deficits’ potential negative effects on
flight safety and mission effectiveness
• Secondary concerns relate to future risk of tumor
recurrence
Aeromedical ConcernsAeromedical Concerns
2424
Acoustic Neuroma - not specifically addressed in Acoustic Neuroma - not specifically addressed in USAF Instruction USAF Instruction
Can be covered under several other headings that Can be covered under several other headings that include: include: History of tumor involving the brain or its coverings History of tumor involving the brain or its coverings History of surgery involving the middle ear, History of surgery involving the middle ear,
excluding cholesteatomaexcluding cholesteatoma Any conditions that interfere with the auditory or Any conditions that interfere with the auditory or
vestibular functionsvestibular functions Hearing loss greater than H-1 profile (25 dB for Hearing loss greater than H-1 profile (25 dB for
500,1000 and 2000 Hz; 35 dB for 3000hz, 45 dB 500,1000 and 2000 Hz; 35 dB for 3000hz, 45 dB for 4000 and 6000 Hz), or asymmetric hearing loss for 4000 and 6000 Hz), or asymmetric hearing loss
USAF Aeromedical USAF Aeromedical DispositionDisposition
• Waiver requests Waiver requests
Submitted six months after successful treatment of the Submitted six months after successful treatment of the
acoustic neuroma acoustic neuroma
Provided any post-treatment sequelae are within Provided any post-treatment sequelae are within
acceptable respective flying-class limitsacceptable respective flying-class limits
• The tumor must be unilateral, and there must be The tumor must be unilateral, and there must be
complete resolution of vertigo after treatmentcomplete resolution of vertigo after treatment
2525
USAF Waiver PolicyUSAF Waiver Policy
• Residual cranial nerve deficits Residual cranial nerve deficits
• Should allow full ocular movements without tracking Should allow full ocular movements without tracking
deficits or strabismusdeficits or strabismus
• Allow for acceptable protective mask sealingAllow for acceptable protective mask sealing
• ENT and neurology consultations are required for ENT and neurology consultations are required for
waiver considerationwaiver consideration
2626
USAF Waiver PolicyUSAF Waiver Policy
• *Must be at least 6 months after definitive *Must be at least 6 months after definitive
treatment and no aeromedically significant new or treatment and no aeromedically significant new or
residual symptoms.residual symptoms.2727
USAF Waiver PolicyUSAF Waiver Policy
2828
Turkish AF (TUAF) RegulationTurkish AF (TUAF) Regulation
•History of central nervous system tumors are History of central nervous system tumors are
disqualifying for flying for any military pilotdisqualifying for flying for any military pilot
•Moderate diseases or their sequelae of central Moderate diseases or their sequelae of central
nervous system nervous system are disqualifying for flying for any are disqualifying for flying for any
military pilotmilitary pilot
•Deafness in one ear isDeafness in one ear is disqualifying for flying for disqualifying for flying for
any military pilotany military pilot
TUAF Aeromedical TUAF Aeromedical DispositionDisposition
TUAF does not grant waivers for any disqualifying TUAF does not grant waivers for any disqualifying
conditioncondition
But if the pilot objects to the decision pilot can But if the pilot objects to the decision pilot can
appeal to the TUAF. There are 4 Aeromedical appeal to the TUAF. There are 4 Aeromedical
Examination Centers and TUAF may refer the pilot Examination Centers and TUAF may refer the pilot
to another one. If the second center decides pilot to another one. If the second center decides pilot
condition is not disqualifying, pilot will be sent to condition is not disqualifying, pilot will be sent to
another aeromedical center for the final decisionanother aeromedical center for the final decision2929
TUAF Waiver PolicyTUAF Waiver Policy
Oct 2012 Oct 2012
Ophthalmology: NLOphthalmology: NL
Internal Medicine: NLInternal Medicine: NL
Psychiatry: NLPsychiatry: NL
Neurology: Needs further information about in-Neurology: Needs further information about in-
flight communication assessment and flight communication assessment and
assessment of vestibular toleranceassessment of vestibular tolerance
3030
ACS EvaluationACS Evaluation
She participated in three operational sorties with She participated in three operational sorties with
two different pilots two different pilots
One sortie was at night and included night-vision One sortie was at night and included night-vision
equipmentequipment
Both pilots reported no difficulty with in-flight Both pilots reported no difficulty with in-flight
communication or speech discrimination communication or speech discrimination
3131
ACS EvaluationACS Evaluation
She had no difficulties with G-tolerance up to She had no difficulties with G-tolerance up to
7.5G, including one prolonged “check six” 7.5G, including one prolonged “check six”
position with turns and G-exposure position with turns and G-exposure
During the night mission she wore night-vision During the night mission she wore night-vision
goggles for two hours and reported no goggles for two hours and reported no
problems, successfully performing the mission problems, successfully performing the mission
3232
ACS EvaluationACS Evaluation
1. Surgically resected right acoustic 1. Surgically resected right acoustic Schwannoma, surgically resected Dec 2011 Schwannoma, surgically resected Dec 2011
2. Postoperative right-sided permanent 2. Postoperative right-sided permanent deafnessdeafness
3. Postoperative right facial weakness, 3. Postoperative right facial weakness, essentially resolved, with no apparent essentially resolved, with no apparent current clinical findings current clinical findings
3333
ACS Evaluation - DiagnosesACS Evaluation - Diagnoses
4. Ocular tracking dysfunction with associated 4. Ocular tracking dysfunction with associated nystagmus, resolved, with no functional nystagmus, resolved, with no functional impairmentimpairment
5. Postoperative CSF leakage, surgically 5. Postoperative CSF leakage, surgically repaired, no recurrencerepaired, no recurrence
6. Unusual genetic variant noted on NF2 6. Unusual genetic variant noted on NF2 mutation analysis, felt to be clinically mutation analysis, felt to be clinically insignificant, not disqualifyinginsignificant, not disqualifying
3434
ACS Evaluation - DiagnosesACS Evaluation - Diagnoses
1. Recommend FC-IIC waiver for diagnoses #1 1. Recommend FC-IIC waiver for diagnoses #1 through #4 (restricted to aircraft and settings that through #4 (restricted to aircraft and settings that do not require stereoacusis), valid for two yearsdo not require stereoacusis), valid for two years
2. Local Neurosurgery and ENT follow-up every year2. Local Neurosurgery and ENT follow-up every year
3. Follow-up brain and internal auditory canal 3. Follow-up brain and internal auditory canal imaging studies imaging studies
4. At time of waiver renewal request, specialist 4. At time of waiver renewal request, specialist notes, report and images from any neuroimaging notes, report and images from any neuroimaging studies, and results of current neurologic and studies, and results of current neurologic and otolaryngologic examination to ACS for reviewotolaryngologic examination to ACS for review
3535
ACS RecommendationsACS Recommendations
3636
AAMIMO 2013AAMIMO 2013 USAFSAMUSAFSAM
Questions?Questions?
Top Related